Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 16 October 2008, doi:10.1136/bmj.a2088
Cite this as: BMJ 2008;337:a2088
Janice Hopkins Tanne
1 New York
| The first 150 words of the full text of this article appear below. |
Charles Nemeroff, a US psychiatrist, has temporarily stepped down as chairman of the department of psychiatry and behavioural sciences at Emory University in Atlanta, Georgia, pending conclusions of investigations into alleged undisclosed payments from drug companies. He remains a professor at the university.
The US Senate Finance Committee has been looking into relations between drug companies and influential doctors and whether drug company funding has influenced the integrity of research and ultimately US doctors prescribing habits.
The committees investigation has found that Dr Nemeroff received funds from several drug companies but did not report them to his university, according to documents posted on the committees website (http://finance.senate.gov/sitepages/hearing091608.htm).
The university issued a statement last week saying, "Senator Charles Grassley (Republican, Iowa) [the leading Republican member on the finance committee] has raised a number of questions about whether Emorys chairman of psychiatry and behavioural sciences, Dr Charles Nemeroff, has properly
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?